Emergent BioSolutions (EBS) Short-term Investments (2010 - 2026)

Emergent BioSolutions' Short-term Investments history runs 11 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 67.57% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 67.57% YoY), while the FY2025 annual figure was $3.7 million, down 39.34% from the prior year.
• Short-term Investments for Q1 2026 stood at $1.2 million, down from $3.7 million in the prior quarter.
• The five-year high for Short-term Investments was $6.5 million in Q3 2024, with the low at $100000.0 in Q3 2022.
• The 4-year median for Short-term Investments is $2.5 million (2024), against an average of $2.6 million.
• The sharpest annual moves came in 2025 and 2026: Short-term Investments surged 640.0% in 2025, then sank 67.57% in 2026.
• Emergent BioSolutions' Short-term Investments stood at $100000.0 in 2022, then surged by 6000.0% to $6.1 million in 2024, then slumped by 39.34% to $3.7 million in 2025, then tumbled by 67.57% to $1.2 million in 2026.
• Business Quant data shows EBS's Short-term Investments at $1.2 million in Q1 2026, $3.7 million in Q4 2025, and $3.7 million in Q3 2025.